TherapeuticsMD (TXMD) Amortizatization of Intangibles (2011 - 2013)
TherapeuticsMD's (TXMD) quarterly Amortizatization of Intangibles came in at $1.1 million in Q1 2013, up 1969.13% YoY from $53292.0 in Q1 2012, and up 147.87% on a QoQ basis from $444865.0 in Q4 2012.
TherapeuticsMD (TXMD) Amortizatization of Intangibles (2011 - 2013) Analysis & Trends
TherapeuticsMD (TXMD) has 3 years of Amortizatization of Intangibles data on file, last reported at $1.1 million in Q1 2013.
- Quarterly Amortizatization of Intangibles rose 1969.13% year-over-year to $1.1 million in Q1 2013, while the trailing twelve-month figure through Dec 2013 was $1.1 million (down 31.26% YoY) and the FY2013 annual result came in at $1.1 million, down 31.26% from the prior year.
- Amortizatization of Intangibles climbed to $1.1 million in Q1 2013, from $444865.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.1 million in Q1 2013 to a low of $3590.0 in Q2 2011.
- A 3-year average of $341954.9 and a median of $51695.5 in 2012 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 29314.6% in 2012, down 248.88% in 2012.
- Tracing TXMD's Amortizatization of Intangibles over 3 years: stood at $10769.0 in 2011, then surged by 4030.98% to $444865.0 in 2012, then surged by 147.87% to $1.1 million in 2013.
- The last three Amortizatization of Intangibles figures came in at $1.1 million (Q1 2013), $444865.0 (Q4 2012), and $50099.0 (Q3 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 234,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 1.10 Mn |
| Mar 31, 2013 | 1.10 Mn |
| Dec 31, 2012 | 444,865.00 |
| Dec 31, 2012 | 444,865.00 |
| Sep 30, 2012 | 50,099.00 |
| Sep 30, 2012 | 50,099.00 |
| Jun 30, 2012 | 1.06 Mn |
| Jun 30, 2012 | 1.06 Mn |
| Mar 31, 2012 | 53,292.00 |
| Mar 31, 2012 | 53,292.00 |
| Dec 31, 2011 | 10,769.00 |
| Dec 31, 2011 | 10,769.00 |
| Sep 30, 2011 | 14,360.00 |
| Sep 30, 2011 | 14,360.00 |
| Jun 30, 2011 | 3,590.00 |
| Jun 30, 2011 | 3,590.00 |